Economic evaluation of stapokibart for chronic rhinosinusitis with nasal polyps in China: a cost–effectiveness analysis
Aim: To evaluate the cost–effectiveness of stapokibart compared with dupilumab in treating chronic rhinosinusitis with nasal polyps (CRSwNP) from the healthcare system perspective in China. The focus is on assessing the economic viability of biologic treatments in managing CRSwNP, particularly whe...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Becaris Publishing Limited
2026-05-01
|
| Σειρά: | Journal of Comparative Effectiveness Research |
| Θέματα: | |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|